---
title: "Brief News: Although there are improvements in the fourth quarter data, JXR's annual business still fell by 1.4%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/271614532.md"
description: "JXR released data showing that the number of in vitro fertilization (IVF) treatments in the fourth quarter of 2025 was 7,004, an increase of 12% year-on-year. Despite a strong performance in the fourth quarter, the total number of IVF treatments for the year still declined by 1.4% to 28,039. The IVF treatments at the Chengdu flagship center rose by 1.3% to 14,070, while overseas business fell by 6.9% to 4,235. On Tuesday, the stock price slightly increased to HKD 2.50, down about 5% over the past 52 weeks"
datetime: "2026-01-06T07:10:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271614532.md)
  - [en](https://longbridge.com/en/news/271614532.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271614532.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/271614532.md) | [繁體中文](https://longbridge.com/zh-HK/news/271614532.md)


# Brief News: Although there are improvements in the fourth quarter data, JXR's annual business still fell by 1.4%

According to data released by the fertility service provider **JXR** (1951.HK) on Monday, it provided 7,004 in vitro fertilization (IVF) treatments to clients in the fourth quarter of last year, a year-on-year increase of 12%. This strong growth reflects the company's business rebounding after a weak performance in early 2025.

After accounting for the strong fourth-quarter performance, the total number of IVF treatments for the entire year of 2025 decreased by 1.4% year-on-year to 28,039, an improvement compared to a 5.2% decline in the first nine months of last year.

The company's flagship center in Chengdu provided 14,070 IVF treatments in 2025, an increase of 1.3% year-on-year, accounting for about half of the total business volume. However, treatments provided by overseas operations decreased by 6.9% year-on-year to 4,235, as the company closed its IVF center in Laos, leaving only the United States for overseas operations.

JXR rose slightly to HKD 2.50 in early trading on Tuesday afternoon, with its stock price down about 5% over the past 52 weeks

### 相关股票

- [JXR (01951.HK)](https://longbridge.com/zh-CN/quote/01951.HK.md)

## 相关资讯与研究

- [Minnesota Sues Federal Government Over Medicaid Funding Freeze](https://longbridge.com/zh-CN/news/277790882.md)
- [COSCIENS Biopharma to Stop Funding Aeterna Zentaris GmbH and Zentaris IVF GmbH](https://longbridge.com/zh-CN/news/278097679.md)
- [14:18 ETHuawei lancia soluzioni specifiche per uffici, strutture sanitarie e istituti scolastici](https://longbridge.com/zh-CN/news/277978824.md)
- [Hong Kong convention centre to host more medical, tech, finance, education events](https://longbridge.com/zh-CN/news/277637150.md)
- [07:26 ETHuawei Launches Scenario-Specific Solutions for Office, Healthcare, and Education](https://longbridge.com/zh-CN/news/277778300.md)